Why You Should Know About Peter Aaby

Peter Aaby, MSc, DMSc is perhaps one of the most important medical researchers of our time that few have ever heard of. Mainstream media outlets, especially in the US, are reluctant to bring attention to his groundbreaking findings. Aaby himself often avoids the spotlight preferring that his body of work speaks for itself. In his home country of Denmark he was named the fifth most important person in the country by the Danish Ministry of Foreign Affairs when it comes to influencing the fight against global poverty. When looking at Aaby’s body of research, one could easily come to the conclusion that he is ‘pro-vaccine.’ However, outside of any polarizing labels is where Aaby and his work live. A gray area that isn’t supposed to exist according to health authorities and vaccine manufacturers. A gray area that few researchers have the courage to venture into. Such an area was once called true science and research. Fearless and without the usual preconceived notions gone rampant today from industry-funded science, statistical manipulation and conflicts of interest.

Aaby has worked for one of Denmarks largest health research facilities called the Staten Serum Institut. In 1978, Aaby established the Bandim Health Project (BHP), a health and demographic surveillance system site in Guinea-Bissau in West Africa. At the time child mortality was very high in Guinea-Bissau. Malnutrition was assumed to be the main cause and a study was, therefore, initiated to determine why children were malnourished. There was no community vaccination program in Guinea-Bissau until BHP, under the direction of Aaby, initiated one in 1981. Later in 1986, a full-fledged national program was implemented with UNICEF support still ongoing today.

According to Aaby, it was in 1989 that he and his research team did “one of the most spectacular things [they] have done.” In 1989 the World Health Organization recommended a new measles vaccine for use in Guinea-Bissau and Senegal vaccination campaigns. Aaby and his team showed that the new vaccine was associated with two times higher female mortality. Aaby estimated that if the vaccine had been generally implemented as planned it would have cost as least a half a million additional female deaths in Africa.

Fast forward to 2017 when Aaby published a bombshell study regarding the catastrophic shortcomings of the diphtheria-tetanus-pertussis (DTP) vaccine. The study from West Africa’s Guinea-Bissau discovered that all-cause infant mortality more than doubled after the introduction of the DTP vaccination. In addition, the study found that children vaccinated with the DTP vaccine were 10 times more likely to die in the first six months of life than those children that were unvaccinated. The international, mainstream scientific community was silent. More alarmingly, UNICEF failed to publicly recognize the study or alter their vaccination programs in light of the new information.

In late 2017, The Informed Consent Action Network (ICAN) sent a legal notice letter to UNICEF and 150 other underdeveloped nations. The letter demanded UNICEF “cease distribution of the DTP vaccine or at least confirm that parents of children receiving this vaccine are advised of Dr. Aaby’s findings, we intend to take appropriate legal action.” After two full months of silence, UNICEF replied to ICANs notice with a canned response completely ignoring Aaby’s study and refusing to withdrawal their DTP vaccination campaigns.

One month later, Aaby went all in publishing another study titled Evidence of Increase in Mortality After the Introduction of Diphtheria–Tetanus–Pertussis Vaccine to Children Aged 6–35 Months in Guinea-Bissau: A Time for Reflection? Along with stronger wording in the title [A Time for Reflection] Aaby and his team concluded the following:

“Although having better nutritional status and being protected against three infections, 6–35 months old DTP-vaccinated children tended to have higher mortality than DTP-unvaccinated children. All studies of the introduction of DTP have found increased overall mortality.”

UNICEF has been silent despite the mainstream scientific community, activists and human rights organizations now voicing their opposition in unison to the DTP vaccine campaigns. With mounting scientific evidence showing realtime consequences and a failure to respond to ICANs legal notice, UNICEF is now in the crosshairs of a monumental legal, moral, ethical and humanitarian disaster in full view of the public as they blindly continue their DTP vaccine campaigns.